Literature DB >> 33127413

Low relative mechanical power in older adults: An operational definition and algorithm for its application in the clinical setting.

Jose Losa-Reyna1, Julian Alcazar2, Irene Rodríguez-Gómez2, Ana Alfaro-Acha3, Luis M Alegre2, Leocadio Rodríguez-Mañas4, Ignacio Ara2, Francisco J García-García5.   

Abstract

INTRODUCTION: The assessment and treatment of low relative muscle power in older people has received little attention in the clinical setting when compared to sarcopenia. Our main goal was to assess the associations of low relative power and sarcopenia with other negative outcomes in older people.
METHODS: The participants were 1189 subjects (54% women; 65-101 years old) from the Toledo Study for Healthy Aging. Probable sarcopenia was defined as having low handgrip strength, while confirmed sarcopenia also included low appendicular skeletal muscle index (assessed by dual energy X-ray absorptiometry) (EWGSOP2's definition). Low relative (i.e. normalized to body mass) muscle power was assessed with the 5-repetition sit-to-stand power test (which uses an equation that converts sit-to-stand performance into mechanical power) and diagnosed in those subjects in the lowest sex-specific tertile. Low usual gait speed (UGS), frailty (according to Fried's criteria and the Frailty Trait Scale), limitations in basic (BADL) and instrumental activities of daily living (IADL) and poor quality of life were also recorded.
RESULTS: Age-adjusted logistic regression analyses demonstrated that low relative muscle power was associated with low UGS (odds ratio (OR) = 1.9 and 2.5), frailty (OR = 3.9 and 4.7) and poor quality of life (OR = 1.8 and 1.9) in older men and women, respectively, and with limitations in BADL (OR = 1.6) and IADL (OR = 3.8) in older women (all p < 0.05). Confirmed sarcopenia was only associated with low UGS (OR = 2.5) and frailty (OR = 5.0) in older men, and with limitations in IADL in older women (OR = 4.3) (all p < 0.05).
CONCLUSIONS: Low relative muscle power had a greater clinical relevance than low handgrip strength and confirmed sarcopenia among older people. An operational definition and algorithm for low relative muscle power case finding in daily clinical practice was presented.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chair stand; Functional ability; Muscle power; Sarcopenia; Sit-to-stand

Mesh:

Year:  2020        PMID: 33127413     DOI: 10.1016/j.exger.2020.111141

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  5 in total

1.  Chair stand test as a proxy for physical performance and muscle strength in sarcopenia diagnosis: the Korean frailty and aging cohort study.

Authors:  Ji Yeon Ryu; Miji Kim; Kyoung Soo Kim; Sunyoung Kim; Chang Won Won
Journal:  Aging Clin Exp Res       Date:  2022-08-02       Impact factor: 4.481

Review 2.  Skeletal Muscle Complications in Chronic Kidney Disease.

Authors:  Ashley D Troutman; Eliott Arroyo; Kenneth Lim; Ranjani N Moorthi; Keith G Avin
Journal:  Curr Osteoporos Rep       Date:  2022-09-23       Impact factor: 5.163

3.  The Medium-Term Changes in Health-Related Behaviours among Spanish Older People Lifestyles during Covid-19 Lockdown.

Authors:  I Rodríguez-Gómez; C Sánchez-Martín; F J García-García; E García-Esquinas; M Miret; D Jiménez-Pavón; A Guadalupe-Grau; A Mañas; J A Carnicero; J A Casajus; J L Ayuso-Mateos; F Rodríguez-Artalejo; L Rodríguez-Mañas; I Ara
Journal:  J Nutr Health Aging       Date:  2022       Impact factor: 5.285

4.  Changes in systemic GDF15 across the adult lifespan and their impact on maximal muscle power: the Copenhagen Sarcopenia Study.

Authors:  Julian Alcazar; Ulrik Frandsen; Tatyana Prokhorova; Rikke S Kamper; Bryan Haddock; Per Aagaard; Charlotte Suetta
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-10-06       Impact factor: 12.910

5.  Relative sit-to-stand power cut-off points and their association with negatives outcomes in older adults.

Authors:  Ivan Baltasar-Fernandez; Julian Alcazar; Asier Mañas; Luis M Alegre; Ana Alfaro-Acha; Leocadio Rodriguez-Mañas; Ignacio Ara; Francisco J García-García; Jose Losa-Reyna
Journal:  Sci Rep       Date:  2021-09-30       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.